Emmanuel Jairaj Moses

Dr. Emmanuel Jairaj Moses

Universiti Sains Malaysia, George Town, Pulau Pinang, Malaysia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2025 in BMC Medicine
Verified
Journal Article
Open access
PDF file
JYJinjin Yu
Jinjin Yu
XLXiaotian Liu
Xiaotian Liu
LJLele Jin
Lele Jin
HLHan Li
Han Li
SWSuhui Wang
Suhui Wang
XZXinxing Zhu
Xinxing Zhu
Numerous studies have highlighted the beneficial effects of mesenchymal stem cells (MSCs) in various inflammatory disorders. However, the regulatory role of MSCs in inflammatory atherosclerosis and the molecular mechanisms underlying their anti-inflammatory properties have largely remained elusive. Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) released by menstrual blood-derived mesenchymal stem cells (MenSCs). An ApoE knockout atherosclerotic animal model was employed to investigate the regulatory effect of MenSC-EVs on inflammatory atherosclerosis. miRNA microarray screening analyses were conducted to identify potential effectors in MenSC-EVs that play a key role in the suppression of atherosclerosis mediated by the EVs. We demonstrated the remarkable potential of MenSC-EVs in alleviating atherosclerosis through the NF-κB signaling pathway. miR-574-5p serves as a crucial effector molecule transported by MenSC-EVs, suppressing endothelial inflammation and promoting nitric oxide production. This regulation contributes to the attenuation of atherosclerosis by regulating the abundance of c-Rel. The miR-574-5p/c-Rel axis shows significant clinical relevance to atherosclerosis. This study reveals that the engineering of EVs derived from MenSCs holds significant promise as a strategic clinical approach for addressing inflammatory atherosclerosis. • MenSC-derived EVs possess an intrinsic ability to suppress inflammatory atherosclerosis. • miR-574 knockout clearly promotes atherosclerotic plaque formation. • The MenSC-EVs lacking miR-574-5p exhibit a diminished therapeutic effect on inflammatory atherosclerosis. • miR-574-5p negatively regulates NF-κB signaling through the posttranscriptional degradation of c-Rel.

21 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JYJinjin Yu
Jinjin Yu
YLYingke Li
Yingke Li
YLYiming Li
Yiming Li
XLXiaotian Liu
Xiaotian Liu
QHQingyang Huo
Qingyang Huo
XZXinxing Zhu
Xinxing Zhu
The transcriptional repressor FOXN3 plays a key role in regulating pulmonary inflammatory responses, which are crucial in the development of pulmonary fibrosis. However, its specific regulatory function in lung fibrosis remains unclear. Here, we show that FOXN3 suppresses pulmonary fibrosis by inhibiting Smad transcriptional activity. FOXN3 targets a substantial number of Smad response gene promoters, facilitating Smad4 ubiquitination, which disrupts the association of the Smad2/3/4 complex with chromatin and abolishes its transcriptional response. In response to pro-fibrotic stimuli, NEK6 phosphorylates FOXN3 at S412 and S416, leading to its degradation. The loss of FOXN3 inhibits β-TrCP-mediated ubiquitination of Smad4, stabilizing the Smad complex’s association with its responsive elements and promoting transcriptional activation, thus contributing to the development of pulmonary fibrosis. Notably, we found a significant inverse expression pattern between FOXN3 and Smad4 in clinical pulmonary fibrosis cases, underscoring the importance of the NEK6-FOXN3-Smad axis in the pathological process of pulmonary fibrosis.

1 February 2022 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YMYee Yik Mot
Yee Yik Mot
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
NYNarazah Mohd Yusoff
Narazah Mohd Yusoff
KLKing-Hwa Ling
King-Hwa Ling
Yoke Keong YongYoke Keong Yong
Yoke Keong Yong
JTJun Jie Tan
Jun Jie Tan

30 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
YMYik Mot
Yik Mot
AAAdam Azlan
Adam Azlan
YRYaashini Rajasegaran
Yaashini Rajasegaran
ARAliaa Rosli
Aliaa Rosli
NYNarazah Mohd Yusoff
Narazah Mohd Yusoff
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
The proliferative capacity and continuous survival of cells are highly dependent on telomerase expression and the maintenance of telomere length. For this reason, elevated expression of telomerase has been identified in virtually all cancers, including leukemias; however, it should be noted that expression of telomerase is sometimes observed later in malignant development. This time point of activation is highly dependent on the type of leukemia and its causative factors. Many recent studies in this field have contributed to the elucidation of the mechanisms by which the various forms of leukemias increase telomerase activity. These include the dysregulation of telomerase reverse transcriptase (TERT) at various levels which include transcriptional, post-transcriptional, and post-translational stages. The pathways and biological molecules involved in these processes are also being deciphered with the advent of enabling technologies such as next-generation sequencing (NGS), ribonucleic acid sequencing (RNA-Seq), liquid chromatography-mass spectrometry (LCMS/MS), and many others. It has also been established that TERT possess diagnostic value as most adult cells do not express high levels of telomerase. Indeed, studies have shown that prognosis is not favorable in patients who have leukemias expressing high levels of telomerase. Recent research has indicated that targeting of this gene is able to control the survival of malignant cells and therefore offers a potential treatment for TERT-dependent leukemias. Here we review the mechanisms of hTERT regulation and deliberate their association in malignant states of leukemic cells. Further, we also cover the clinical implications of this gene including its use in diagnostic, prognostic, and therapeutic discoveries.

19 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
YRYaashini Rajasegaran
Yaashini Rajasegaran
AAAdam Azlan
Adam Azlan
ARAliaa Arina Rosli
Aliaa Arina Rosli
YMYik Mot
Yik Mot
KZKhor Kang Zi
Khor Kang Zi
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
MicroRNAs (miRNAs) are short non-coding RNAs involved in post-transcriptional gene regulation. Over the past years, various studies have demonstrated the role of aberrant miRNA expression in the onset of cancer. The mechanisms by which miRNA exerts its cancer-promoting or inhibitory effects are apparent through the various cancer hallmarks, which include selective proliferative advantage, altered stress response, vascularization, invasion and metastasis, metabolic rewiring, the tumor microenvironment and immune modulation; therefore, this review aims to highlight the association between miRNAs and the various cancer hallmarks by dissecting the mechanisms of miRNA regulation in each hallmark separately. It is hoped that the information presented herein will provide further insights regarding the role of cancer and serve as a guideline to evaluate the potential of microRNAs to be utilized as biomarkers and therapeutic targets on a larger scale in cancer research.

10 March 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
TRThevendran Ramesh
Thevendran Ramesh
KFKai Loong Foo
Kai Loong Foo
Mohd Hazwan HussinMohd Hazwan Hussin
Mohd Hazwan Hussin
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
MCMarimuthu Citartan
Marimuthu Citartan
SMSolayappan Maheswaran
Solayappan Maheswaran
Detection of genetic mutations leading to hematological malignancies is a key factor in the early diagnosis of acute myeloid leukemia (AML). FLT3-ITD mutations are an alarming gene defect found commonly in AML patients associated with high cases of leukemia and low survival rates. Available diagnostic assessments for FLT3-ITD are incapable of combining cost-effective detection platforms with high analytical performances. To circumvent this, we developed an efficient DNA biosensor for the recognition of AML caused by FLT3-ITD mutation utilizing electrochemical impedance characterization. The system was designed by adhering gold-sputtered zinc oxide (ZnO) nanorods onto interdigitated electrode (IDE) sensor chips. The sensing surface was biointerfaced with capture probes designed to hybridize with unmutated FLT3 sequences instead of the mutated FLT3-ITD gene, establishing a reverse manner of target detection. The developed biosensor demonstrated specific detection of mutated FLT3 genes, with high levels of sensitivity in response to analyte concentrations as low as 1 nM. The sensor also exhibited a stable functional life span of more than five weeks with good reproducibility and high discriminatory properties against FLT3 gene targets. Hence, the developed sensor is a promising tool for rapid and low-cost diagnostic applications relevant to the clinical prognosis of AML stemming from FLT3-ITD mutations.